Companies: 10,795·Total market cap: $144.5T
Novo Nordisk A/S

Novo Nordisk A/S

NONOFOTCHealthcare● Active
$42.27
$-1.10(-2.53%)
Market Cap$187.8B
P/E Ratio
52W High$82.5
52W Low$34
Overview

Novo Nordisk A/S(NONOF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NONOF · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$308.36B$290.40B$232.26B$176.95B$140.80B
Cost of Revenue$60.62B$44.52B$35.77B$28.45B$23.66B
Gross Profit$247.74B$245.88B$196.50B$148.51B$117.14B
Gross Margin %(computed)80.34%84.67%84.60%83.92%83.20%
Operating Expenses
R&D Expenses$45.12B$48.06B$32.44B$24.05B$17.77B
G&A Expenses$5.97B$5.28B$4.86B$4.47B$4.05B
Total Operating Expenses$113.03B$117.54B$93.92B$73.70B$58.50B
Operating Income$134.71B$128.34B$102.57B$74.81B$58.64B
Operating Margin %(computed)43.69%44.19%44.16%42.28%41.65%
Interest Income$1.27B$1.84B$1.07B$0.24B$0.23B
Interest Expense$4.21B$1.64B$0.74B$0.38B$0.29B
Income Before Tax$130.24B$127.19B$104.67B$69.25B$59.08B
Income Tax Expense$28.04B$26.20B$20.99B$13.54B$11.32B
Net Income$102.20B$100.99B$83.68B$55.52B$47.76B
Net Margin %(computed)33.14%34.78%36.03%31.38%33.92%
Per Share & EBITDA
EPS (Basic)$23.00$22.68$9.34$12.26$10.40
Wtd Avg Shares4.44B4.45B4.49B4.53B4.59B
EBITDA$149.10B$137.38B$111.04B$76.80B$64.83B
EBITDA Margin %(computed)48.35%47.31%47.81%43.40%46.04%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · DKK · B

深入了解Novo Nordisk A/S

关于Novo Nordisk A/S(NONOF)损益表

Novo Nordisk A/S(NONOF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NONOF实现营收$308.36B,毛利润$247.74B(毛利率80.34%),净利润$102.20B(净利率33.14%)。

常见问题

NONOF · 4 问

Novo Nordisk A/S(NONOF)2025财年营收为$308.36B,同比up6.2%。

NONOF revenueNONOF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08